Use of the ulcerative colitis endoscopic index of severity and Mayo endoscopic score for predicting the therapeutic effect of mesalazine in patients with ulcerative colitis - ScienceDirect
Cochrane
Inflammatory Bowel Disease-Associated Interleukin-33 Is Preferentially Expressed in Ulceration-Associated Myofibroblasts - The American Journal of Pathology
A comparison of physician-rated disease severity and patient reported outcomes in mild to moderately active ulcerative colitis
Inflammatory Bowel Disease | Clinical Gate
Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions - Clinical Gastroenterology and Hepatology
Once-Daily Budesonide MMX® Extended-Release Tablets Induce Remission in Patients With Mild to Moderate Ulcerative Colitis: Results From the CORE I Study - Gastroenterology
Modifi ed Mayo Disease Activity Index (MMDAI) a | Download Table
The Efficacy of the Consumption of n-3 Polyunsaturated Fatty Acids for the Maintenance of Remission in Patients with Inflammatory Bowel Disease
New approaches in the follow-up of patients suffering from inflammatory bowel diseases
Summary of activity indices used for ulcerative colitis | Download Table
Cells | Free Full-Text | A Phase 2a, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis
Metabolites | Free Full-Text | Mucosal Metabolomic Profiling and Pathway Analysis Reveal the Metabolic Signature of Ulcerative Colitis | HTML
PDF] Correlation of endoscopic disease severity with pediatric ulcerative colitis activity index score in children and young adults with ulcerative colitis | Semantic Scholar
Modifi ed Mayo Disease Activity Index (MMDAI) a | Download Table
Epidermal Growth Factor Enemas with Oral Mesalamine for Mild-to-Moderate Left-Sided Ulcerative Colitis or Proctitis | NEJM
Remission endpoints in ulcerative colitis: A systematic review
CDAI calculator (Crohn's Disease Activity Index)
Disease activity index (Schroeder and colleagues 14 ) | Download Table
Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study | Gut
Remission endpoints in ulcerative colitis: A systematic review
Diagnosis of acute severe colitis
WO2014096873A1 - Biomarkers in inflammatory bowel disease - Google Patents
Use of the ulcerative colitis endoscopic index of severity and Mayo endoscopic score for predicting the therapeutic effect of mesalazine in patients with ulcerative colitis - ScienceDirect
WO2014096873A1 - Biomarkers in inflammatory bowel disease - Google Patents
Scores on Harvey Bradshaw Index (HB) and Ulcerative Colitis Disease... | Download Scientific Diagram
Systematic review with meta‐analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitis - Ma - 2018 - Alimentary Pharmacology & Therapeutics - Wiley Online Library